Join
Live feed
·
INSIDERFilingvia Quantisnow
Emergent BioSolutions Inc. logo

EVP, Chief Financial Officer Lindahl Richard S returned $504,013 worth of shares to the company (46,155 units at $10.92) and covered exercise/tax liability with 5,642 shares, decreasing direct ownership by 18% to 239,700 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
EBS· Emergent BioSolutions Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EBS (Emergent BioSolutions Inc.) and more on Quantisnow.